Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Pliant Therapeutics Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Pliant Therapeutics Inc tiene un total de activos de $396, una ganancia neta loss de $-210

Question 2

¿Cuáles son los ratios financieros clave para PLRX?

Accepted Answer

El ratio corriente de Pliant Therapeutics Inc es 4.3, el margen neto es 0, las ventas por acción son $0.

Question 3

¿Cómo se desglosan los ingresos de Pliant Therapeutics Inc por segmento o geografía?

Accepted Answer

Pliant Therapeutics Inc largest revenue segment is Novel Therapies, at a revenue of 1,580,000 in the most earnings release.For geography, United States is the primary market for Pliant Therapeutics Inc, at a revenue of 1,580,000.

Question 4

¿Es rentable Pliant Therapeutics Inc?

Accepted Answer

no, según los últimos estados financieros, Pliant Therapeutics Inc tiene una ganancia neta loss de $-210

Question 5

¿Tiene Pliant Therapeutics Inc alguna deuda?

Accepted Answer

yes, Pliant Therapeutics Inc tiene una deuda de 92

Question 6

¿Cuántas acciones en circulación tiene Pliant Therapeutics Inc?

Accepted Answer

Pliant Therapeutics Inc tiene un total de acciones en circulación de 60.86

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	1	9	7	41
Revenue Growth (YoY)	--	-100%	-89%	28.99%	-83%	-28%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	56	59	57	39	27	17
Research & Development	159	169	127	96	77	66
Operating Expenses	216	228	185	136	105	83
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	-206	-210	-161	-123	-97	-41
Income Tax Expense	0	0	--	--	--	--
Net Income	-206	-210	-161	-123	-97	-41
Net Income Growth	11%	30%	31%	27%	137%	583%
Shares Outstanding (Diluted)	61.38	60.53	58.71	42.02	35.85	21.34
Shares Change (YoY)	2%	3%	40%	17%	68%	-38%
EPS (Diluted)	-3.39	-3.47	-2.74	-2.94	-2.71	-1.95
EPS Growth	10%	26%	-7%	8%	39%	875%
Free Cash Flow	-170	-159	-117	-96	-77	-38
Free Cash Flow Per Share	-2.76	-2.62	-1.99	-2.28	-2.14	-1.78
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-18,400%	-1,411.11%	-1,385.71%	-100%
Profit Margin	0%	0%	-16,100%	-1,366.66%	-1,385.71%	-100%
Free Cash Flow Margin	0%	0%	-11,700%	-1,066.66%	-1,100%	-92.68%
EBITDA	-215	-226	-183	-126	-96	-40
EBITDA Margin	0%	0%	-18,300%	-1,400%	-1,371.42%	-97.56%
D&A For EBITDA	1	2	1	1	1	1
EBIT	-216	-228	-184	-127	-97	-41
EBIT Margin	0%	0%	-18,400%	-1,411.11%	-1,385.71%	-100%
Effective Tax Rate	0%	0%	--	--	--	--

Pliant Therapeutics Inc (PLRX) Price

PLRX Stock Price Chart

PLRX Income

Follow-Up Questions